POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis by Menzies, Alexander M, Long, Georgina V, Kohn, Amiee, Tawbi, Hussein, Weber, Jeffrey, Flaherty, Keith, McArthur, Grant A, Ascierto, Paolo A, Pfluger, Yanina, Lewis, Karl, Tsai, Katy K, Hamid, Omid, Prenen, Hans, Fein, Luis, Wang, Erjian, Guenzel, Carolin, Zhang, Fan, Kleha, Joseph F, di Pietro, Alessandra, Davies, Michael A

Get full text